1. From the National Cancer Institute of Canada Clinical Trials GroupQueen’s University, Kingston, Canada; Department of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; and Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT.